These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 36563698)
41. Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening. Heuvelmans MA; Vliegenthart R; Oudkerk M J Thorac Imaging; 2015 Mar; 30(2):101-7. PubMed ID: 25635703 [TBL] [Abstract][Full Text] [Related]
42. Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors. Poon C; Haderi A; Roediger A; Yuan M Health Policy; 2022 Sep; 126(9):879-888. PubMed ID: 35750552 [TBL] [Abstract][Full Text] [Related]
43. Improving selection criteria for lung cancer screening. The potential role of emphysema. Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622 [TBL] [Abstract][Full Text] [Related]
44. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs. Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157 [TBL] [Abstract][Full Text] [Related]
45. European and North American lung cancer screening experience and implications for pulmonary nodule management. Nair A; Hansell DM Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100 [TBL] [Abstract][Full Text] [Related]
46. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. Yip R; Henschke CI; Yankelevitz DF; Smith JP Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929 [TBL] [Abstract][Full Text] [Related]
47. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography. Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294 [TBL] [Abstract][Full Text] [Related]
48. Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations. Heuvelmans MA; Vonder M; Rook M; Groen HJM; De Bock GH; Xie X; Ijzerman MJ; Vliegenthart R; Oudkerk M J Thorac Imaging; 2019 May; 34(3):160-169. PubMed ID: 30550403 [TBL] [Abstract][Full Text] [Related]
49. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials. Silva M; Pastorino U; Sverzellati N Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954 [TBL] [Abstract][Full Text] [Related]
50. Pearls and Pitfalls in Lung Cancer CT Screening. Godoy MCB; Lago EAD; Pria HRFD; Shroff GS; Strange CD; Truong MT Semin Ultrasound CT MR; 2022 Jun; 43(3):246-256. PubMed ID: 35688535 [TBL] [Abstract][Full Text] [Related]
51. CT screening for lung cancer: countdown to implementation. Field JK; Hansell DM; Duffy SW; Baldwin DR Lancet Oncol; 2013 Dec; 14(13):e591-600. PubMed ID: 24275132 [TBL] [Abstract][Full Text] [Related]
52. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial. Guldbrandt LM Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876 [TBL] [Abstract][Full Text] [Related]
53. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314 [TBL] [Abstract][Full Text] [Related]
54. Issues with implementing a high-quality lung cancer screening program. Mulshine JL; D'Amico TA CA Cancer J Clin; 2014; 64(5):352-63. PubMed ID: 24976072 [TBL] [Abstract][Full Text] [Related]
55. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening. Curl PK; Kahn JG; Ordovas KG; Elicker BM; Naeger DM AJR Am J Roentgenol; 2015 Aug; 205(2):344-7. PubMed ID: 26204285 [TBL] [Abstract][Full Text] [Related]
56. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. Oudkerk M; Liu S; Heuvelmans MA; Walter JE; Field JK Nat Rev Clin Oncol; 2021 Mar; 18(3):135-151. PubMed ID: 33046839 [TBL] [Abstract][Full Text] [Related]
57. [Screening for lung cancer using CT: time for implementation?]. de Jong PA; Lammers JW Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184 [TBL] [Abstract][Full Text] [Related]
58. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model. Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023 [TBL] [Abstract][Full Text] [Related]
59. ESR/ERS white paper on lung cancer screening. Kauczor HU; Bonomo L; Gaga M; Nackaerts K; Peled N; Prokop M; Remy-Jardin M; von Stackelberg O; Sculier JP; ; Eur Radiol; 2015 Sep; 25(9):2519-31. PubMed ID: 25929939 [TBL] [Abstract][Full Text] [Related]
60. [Lung cancer screening: Update, news and perspectives]. Wang P; Chapron J; Bennani S; Revel MP; Wislez M Bull Cancer; 2023 Jan; 110(1):42-54. PubMed ID: 36496261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]